Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLG
1826
Flagstar Bank National Association
FLG
$5.82B
| $5.96M | ﹤0.01% |
165,327
+7,568
| +5% | +$279K |
|
|
NUAN
1827
DELISTED
Nuance Communications, Inc.
NUAN
| $5.96M | ﹤0.01% |
334,027
-232,713
| -41% | -$3.86M |
|
1828
UFP Industries
UFPI
$5.19B
| $5.95M | ﹤0.01% |
124,652
+29,175
| +31% | +$1.37M |
|
1829
CALL
DXC Technology
DXC
$1.73B
| $5.92M | ﹤0.01% |
157,400
+125,800
| +398% | +$4.1M |
|
|
KL
1830
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $5.91M | ﹤0.01% |
134,198
+124,618
| +1,301% | +$5.53M |
|
1831
PUT
Rio Tinto
RIO
$164B
| $5.91M | ﹤0.01% |
99,584
-1,107,516
| -92% | -$60.1M |
|
|
AAT
1832
American Assets Trust
AAT
$1.4B
| $5.91M | ﹤0.01% |
128,683
+9,233
| +8% | +$431K |
|
1833
LCI Industries
LCII
$2.65B
| $5.9M | ﹤0.01% |
55,092
+10,587
| +24% | +$1.07M |
|
1834
PUT
Eli Lilly
LLY
$1.06T
| $5.9M | ﹤0.01% |
44,900
+900
| +2% | +$104K |
|
1835
Omnicell
OMCL
$1.68B
| $5.9M | ﹤0.01% |
72,199
+31,441
| +77% | +$2.41M |
|
1836
Tandem Diabetes Care
TNDM
$1.56B
| $5.88M | ﹤0.01% |
98,621
+64,409
| +188% | +$3.97M |
|
|
NSA
1837
DELISTED
National Storage Affiliates Trust
NSA
| $5.88M | ﹤0.01% |
174,759
-46,135
| -21% | -$1.55M |
|
1838
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$293M
| $5.87M | ﹤0.01% |
182
+171
| +1,555% | +$7.88M |
|
|
PRSP
1839
DELISTED
Perspecta Inc. Common Stock
PRSP
| $5.87M | ﹤0.01% |
221,952
+98,154
| +79% | +$2.61M |
|
1840
NNN REIT
NNN
$8.99B
| $5.87M | ﹤0.01% |
109,366
+23,337
| +27% | +$1.3M |
|
|
CSII
1841
PUT
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.87M | ﹤0.01% |
+120,700
| New | +$5.5M |
|
1842
CALL
Cardinal Health
CAH
$55.4B
| $5.85M | ﹤0.01% |
115,600
+30,100
| +35% | +$1.55M |
|
|
HTZ
1843
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $5.84M | ﹤0.01% |
370,864
-81,942
| -18% | -$1.23M |
|
1844
PUT
Takeda Pharmaceutical
TAK
$55.7B
| $5.83M | ﹤0.01% |
295,717
-300
| -0.1% | -$5.74K |
|
1845
Exponent
EXPO
$3.24B
| $5.82M | ﹤0.01% |
84,377
+19,088
| +29% | +$1.26M |
|
1846
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$531M
| $5.82M | ﹤0.01% |
6,974
+1,932
| +38% | +$1.23M |
|
1847
PUT
Zscaler
ZS
$27.3B
| $5.81M | ﹤0.01% |
125,000
-111,500
| -47% | -$5.17M |
|
1848
Iovance Biotherapeutics
IOVA
$2.87B
| $5.8M | ﹤0.01% |
209,681
+104,169
| +99% | +$2.37M |
|
1849
CALL
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.47B
| $5.79M | ﹤0.01% |
80,400
+9,200
| +13% | +$578K |
|
1850
Elanco Animal Health
ELAN
$11.1B
| $5.77M | ﹤0.01% |
196,049
-189,829
| -49% | -$5.16M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.